These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21963471)

  • 1. Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach.
    Sou T; Orlando L; McIntosh MP; Kaminskas LM; Morton DA
    Int J Pharm; 2011 Dec; 421(2):220-9. PubMed ID: 21963471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
    Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
    Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle size dependence of polymorphism in spray-dried mannitol.
    Lee YY; Wu JX; Yang M; Young PM; van den Berg F; Rantanen J
    Eur J Pharm Sci; 2011 Sep; 44(1-2):41-8. PubMed ID: 21699976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new inhalable thymopentin formulation.
    Wang L; Zhang Y; Tang X
    Int J Pharm; 2009 Jun; 375(1-2):1-7. PubMed ID: 19443146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Mar; 7(3):343-53. PubMed ID: 15515142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS; Abnous K; Tafaghodi M
    Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS; Purewal TS; Alpar OH
    J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
    Karimi K; Pallagi E; Szabó-Révész P; Csóka I; Ambrus R
    Drug Des Devel Ther; 2016; 10():3331-3343. PubMed ID: 27784991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
    Maa YF; Costantino HR; Nguyen PA; Hsu CC
    Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder inhalations containing thymopentin and its immunomodulating effects in Wistar rats.
    Gao J; Ding X; Chu C; Lu L; Zhang Y; Chen Y; Fan W; Li G; Gao S
    Eur J Pharm Sci; 2009 Mar; 36(4-5):572-9. PubMed ID: 19135531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
    Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance.
    Yang Y; Yang Z; Ren Y; Mei X
    Drug Deliv; 2014 Sep; 21(6):480-6. PubMed ID: 24491208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.